Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3

Immunogenetics

Volumn 59, Issue 10, 2007, Pages 779-792

  Luo, Lihui ^a   Du, Zeying ^a   Sharma, Surendra K ^b   Cullen, Rebecca ^c   Spellman, Stephen ^c   Reed, Elaine F ^a   Rajalingam, Raja ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

Gene regulation; HLA; KIR gene; Natural killer cells; Null alleles

Indexed keywords

2DS3 PROTEIN; 3DS1 PROTEIN; DNA; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DNA SEQUENCE; EUROPE; GENE MUTATION; HUMAN; LIGAND BINDING; MOLECULE; NUCLEOTIDE SEQUENCE; NULL ALLELE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SAMPLE;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LINKAGE DISEQUILIBRIUM; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, KIR; RECEPTORS, KIR3DS1; SEQUENCE ANALYSIS;

EID: 35348876096     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-007-0239-1     Document Type: Article

References (100)

1. Abi-Rached L, Parham P (2005) Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 201:1319-1332
2. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326
3. Biassoni R, Pessino A, Malaspina A, Cantoni C, Bottino C, Sivori S, Moretta L, Moretta A (1997) Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 27:3095-3099
4. Biron CA, Brossay L (2001) NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 13:458-464
5. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD (2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405:537-543
6. Carr WH, Pando MJ, Parham P (2005) KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175:5222-5229
7. Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, Lanier LL (2007) Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178:647-651
8. Carrington M, Cullen M (2004) Justified chauvinism: advances in defining meiotic recombination through sperm typing. Trends Genet 20:196-205
9. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M (1994) NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180:1235-1242
10. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL (1993) HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A 90:12000-12004
11. Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C, Moisan JP, Gagne K, Partanen J, Bignon JD (2005) Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66:267-276
12. Diefenbach A, Raulet DH (2002) The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 188:9-21
13. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M (1996) A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 156:3098-3101
14. Du Z, Gjertson DW, Reed EF, Rajalingam R (2007) Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59:1-15
15. Fan QR, Long EO, Wiley DC (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2:452-460
16. Freimer NB, Sabatti C (2005) Guidelines for association studies in Human Molecular Genetics. Hum Mol Genet 14:2481-2483
17. French AR, Yokoyama WM (2003) Natural killer cells and viral infections. Curr Opin Immunol 15:45-51
18. Garcia CA, Robinson J, Guethlein LA, Parham P, Madrigal JA, Marsh SG (2003) Human KIR sequences 2003. Immunogenetics 55:227-239
19. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, Vilches C, Parham P (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166:2992-3001
20. Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT (2005) Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 6:683-690
21. Gendzekhadze K, Norman PJ, Abi-Rached L, Layrisse Z, Parham P (2006) High KIR diversity in Amerindians is maintained using few gene-content haplotypes. Immunogenetics 58(5-6):474-480
22. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C (2002) Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 54:314-319
23. Goodridge JP, Witt CS, Christiansen FT, Warren HS (2003) KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 171:1768-1774
24. Goodridge JP, Lathbury LJ, Steiner NK, Shulse CN, Pullikotil P, Seidah NG, Hurley CK, Christiansen FT, Witt CS (2007) Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol 37:199-211
25. Grendell RL, Hughes AL, Golos TG (2001) Cloning of rhesus monkey killer-cell Ig-like receptors (KIRs) from early pregnancy decidua. Tissue Antigens 58:329-334
26. Guethlein LA, Flodin LR, Adams EJ, Parham P (2002) NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C. J Immunol 169:220-229
27. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133-1144
28. Gutierrez-Rodriguez ME, Sandoval-Ramirez L, Diaz-Flores M, Marsh SG, Valladares-Salgado A, Madrigal JA, Mejia-Arangure JM, Garcia CA, Huerta-Zepeda A, Ibarra-Cortes B, Ortega-Camarillo C, Cruz M (2006) KIR gene in ethnic and Mestizo populations from Mexico. Hum Immunol 67:85-93
29. Halfpenny IA, Middleton D, Barnett YA, Williams F (2004) Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum Immunol 65:602-612
30. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34:1673-1679
31. Hattersley AT, McCarthy MI (2005) What makes a good genetic association study? Lancet 366:1315-1323
32. Hershberger KL, Shyam R, Miura A, Letvin NL (2001) Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol 166:4380-4390
33. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
34. Hsu KC, Chida S, Geraghty DE, Dupont B (2002a) The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 190:40-52
35. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B (2002b) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169:5118-5129
36. Jiang K, Zhu FM, Lv QF, Yan LX (2005) Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens 65:556-563
37. Khakoo SI, Carrington M (2006) KIR and disease: a model system or system of models? Immunol Rev 214:186-201
38. Khakoo SI, Rajalingam R, Shum BP, Weidenbach K, Flodin L, Muir DG, Canavez F, Cooper SL, Valiante NM, Lanier LL, Parham P (2000) Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12:687-698
39. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874
40. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225-274
41. Lau M, Park MS, Terasaki PI (1997) International Cell Exchange 1974-1996, a 23-year documentation. In: Gjertson DW (ed) HLA 1997. 85-124., pp 85-124, UCLA Tissue Typing Laboratory, Los Angeles
42. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244
43. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B, Pruneda L, Couto AR, Gonzalez S, Lopez-Vazquez A, Martinez-Borra J (2006) Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 8:R101
44. Lopez-Vazquez A, Mina-Blanco A, Martinez-Borra J, Njobvu PD, Suarez-Alvarez B, Blanco-Gelaz MA, Gonzalez S, Rodrigo L, Lopez-Larrea C (2005) Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol 66:285-289
45. Maenaka K, Juji T, Nakayama T, Wyer JR, Gao GF, Maenaka T, Zaccai NR, Kikuchi A, Yabe T, Tokunaga K, Tadokoro K, Stuart DI, Jones EY, van der Merwe PA (1999) Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem 274:28329-28334
46. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 62:79-86
47. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31:429-434
48. Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M (2003) Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 171:2192-2195
49. Martin AM, Kulski JK, Gaudieri S, Witt CS, Freitas EM, Trowsdale J, Christiansen FT (2004) Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 335:121-131
50. Maxwell LD, Wallace A, Middleton D, Curran MD (2002) A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60:254-258
51. McQueen KL, Parham P (2002) Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14:615-621
52. Middleton D, Meenagh A, Gourraud PA (2007) KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59:145-158
53. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 93:12433-12438
54. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173:4273-4276
55. Nikitina-Zake L, Rajalingam R, Rumba I, Sanjeevi CB (2004) Killer Cell Immunoglobulin-like Receptor Genes in Latvian Patients with Type 1 Diabetes Mellitus and Healthy Controls. Ann NY Acad Sci 1037:161-169
56. Niokou D, Spyropoulou-Vlachou M, Darlamitsou A, Stavropoulos-Giokas C (2003) Distribution of killer cell immunoglobulin-like receptors in the Greek population. Hum Immunol 64:1167-1176
57. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW (2001) Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52:195-205
58. Norman PJ, Carrington CV, Byng M, Maxwell LD, Curran MD, Stephens HA, Chandanayingyong D, Verity DH, Hameed K, Ramdath DD, Vaughan RW (2002) Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 3:86-95
59. O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178:235-241
60. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P (2003) The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1. J Immunol 171:6640-6649
61. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L (1996) The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184:505-518
62. Peruzzi M, Parker KC, Long EO, Malnati MS (1996) Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157:3350-3356
63. Phillips JH, Gumperz JE, Parham P, Lanier LL (1995) Superantigen- dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403-405
64. Rajagopalan S, Long EO (1997) The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185:1523-1528
65. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P (2001a) Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 57:22-31
66. Rajalingam R, Hong M, Adams EJ, Shum BP, Guethlein LA, Parham P (2001b) Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med 193:135-146
67. Rajalingam R, Krausa P, Shilling HG, Stein JB, Balamurugan A, McGinnis MD, Cheng NW, Mehra NK, Parham P (2002) Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics 53:1009-1019
68. Rajalingam R, Ge P, Reed EF (2004a) A sequencing-based typing method for HLA-DQA1 alleles. Hum Immunol 65:373-379
69. Rajalingam R, Parham P, Abi-Rached L (2004b) Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol 172:356-369
70. Santin I, de Nanclares GP, Calvo B, Gaafar A, Castano L, Bilbao JR (2006) Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus. Hum Immunol 67:118-124
71. Selvakumar A, Steffens U, Dupont B (1997) Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 155:183-196
72. Shilling HG, Lienert-Weidenbach K, Valiante NM, Uhrberg M, Parham P (1998) Evidence for recombination as a mechanism for KIR diversification. Immunogenetics 48:413-416
73. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P (2002) Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168:2307-2315
74. Steffens U, Vyas Y, Dupont B, Selvakumar A (1998) Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens 51:398-413
75. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E (2005) Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 102:13224-13229
76. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, Easterbrook P, McVicar DW, Maenaka K, Parham P, Carrington M, Dong T, Rowland-Jones S (2007) Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178:33-37
77. Toneva M, Lepage V, Lafay G, Dulphy N, Busson M, Lester S, Vu-Trien A, Michaylova A, Naumova E, McCluskey J, Charron D (2001) Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57:358-362
78. Trompeter HI, Gomez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C, Uhrberg M (2005) Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol 174:4135-4143
79. Trowsdale J (2001) Genetic and functional relationships between MHC and NK receptor genes. Immunity 15:363-374
80. Trundley A, Frebel H, Jones D, Chang C, Trowsdale J (2007) Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur J Immunol
81. Uhrberg M, Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P (2001) The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 166:3923-3932
82. Uhrberg M, Parham P, Wernet P (2002) Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54:221-229
83. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P (1997) Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 155:155-164
84. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52:2639-2642
85. VandenBussche CJ, Dakshanamurthy S, Posch PE, Hurley CK (2006) A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J Immunol 177:5347-5357
86. Velickovic M, Velickovic Z, Dunckley H (2006) Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations. Immunogenetics
87. Vilches C, Parham P (2002) KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20:217-251
88. Vilches C, Gardiner CM, Parham P (2000) Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 165:6416-6421
89. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO (1995) Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439-449
90. Whang DH, Park H, Yoon JA, Park MH (2005) Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. Hum Immunol 66:146-154
91. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, Trowsdale J (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 97:4778-4783
92. Winter CC, Long EO (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 158:4026-4028
93. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161:571-577
94. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT (1999) Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 68:1784-1789
95. Witt CS, Martin A, Christiansen FT (2000) Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens 56:248-257
96. Yawata M, Yawata N, Abi-Rached L, Parham P (2002a) Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol 22:463-482
97. Yawata M, Yawata N, McQueen KL, Cheng NW, Guethlein LA, Rajalingam R, Shilling HG, Parham P (2002b) Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 54:543-550
98. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203:633-645
99. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193:1159-1167
100. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE (1997) Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A 94:6313-6318